Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

5801–5825 of 17772

SevereFDA (Drugs)·D-1611-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets because they were manufactured under conditions associated with subpotent products.
Product
WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5850-2 ; b) 30 Tablets, NDC 64727-5850-4; c) 60 Tablets, NDC 64727-5850-5; d) 90 Tablets, NDC 64727-5850-6; e) 100 Tablets, NDC 64727-5850-1; Rx only, Manufactured by: RLC Labs P
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1597-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets nationwide because they were manufactured under conditions found to be subpotent.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 6.75 mcg and levothyroxine (T4) 28.5 mcg], 3/4 Grain (48.75 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3302-4; b) 60-count bottles, NDC 64727-3302-5; c) 90-count bottles, NDC 64727-3302-6; d) 100-count bottles, NDC 64727-
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1606-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The products were manufactured under conditions found to be subpotent.
Product
WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-5450-4; b) 60-count bottles, NDC 64727-5450-5; c) 90-count bottles, NDC 64727-5450-6; d) 100-count bottle
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1579-2020·2020-09-23
Scent Theory Hand Sanitizer Recalled for Methanol Contamination
Scent Theory KEEP IT CLEAN hand sanitizer is being recalled because it was manufactured in a facility where methanol contamination was found.
Product
scent theory KEEP IT CLEAN, pure clean,(Ethyl Alcohol 70%), 16.9 FL OZ/500 mL, Distributed by Scent Theory Products, LLC New York, NY 10018, Made in Mexico, UPC 8 40038 21434 1
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1603-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The product was manufactured under conditions associated with subpotency.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4) 85.5 mcg], 2.25 Grain (146.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3309-4; b) 60-count bottles, NDC 64727-3309-5; c) 90-count bottles, NDC 64727-3309-6; d) 100-count bottles, NDC 647
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1602-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets because they were manufactured under conditions found to be subpotent.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 mcg], 2 Grain (130 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3308-4; b) 60-count bottles, NDC 64727-3308-5; c) 90-count bottles, NDC 64727-3308-6; d) 100-count bottles, NDC 64727-3308-1;
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1599-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The product was manufactured under conditions found to be subpotent.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 11.25 mcg and levothyroxine (T4) 47.5 mcg], 1.25 Grain (81.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3303-4; b) 60-count bottles, NDC 64727-3303-5; c) 90-count bottles, NDC 64727-3303-6; d) 100-count bottles, NDC 647
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1612-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets because they were manufactured under conditions associated with subpotent products.
Product
WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 Tablets, NDC 64727-6150-4; c) 60 Tablets, NDC 64727-6150-5; d) 90 Tablets, NDC 64727-6150-6; e) 100 Tablets, NDC 64727-6150-1; Rx only, Manufactured by: RLC Labs
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1610-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets because they were manufactured under conditions found to be subpotent. The recall covers lots expiring between October 2020 and July 2023.
Product
WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs P
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1604-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets because they were manufactured under conditions associated with subpotency. The recall covers all lots with expiry dates between October 2020 and July 2023.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 mcg], 2.5 Grain (162.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3310-4; b) 60-count bottles, NDC 64727-3310-5; c) 90-count bottles, NDC 64727-3310-6; d) 100-count bottles, NDC 64727-33
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1598-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets due to manufacturing deviations. The products were manufactured under conditions found to be subpotent.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) 19 mcg], 1/2 Grain (32.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3299-4; b) 60-count bottles, NDC 64727-3299-5; c) 90-count bottles, NDC 64727-3299-6; d) 100-count bottles, NDC 64727-3299
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1613-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets because they were manufactured under conditions found to be subpotent. The recall covers lots expiring between October 2020 and July 2023.
Product
WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5950-2 ; b) 30 Tablets, NDC 64727-5950-4; c) 60 Tablets, NDC 64727-5950-5; d) 90 Tablets, NDC 64727-5950-6; e) 100 Tablets, NDC 64727-5950-1; Rx Only, Manufactured by: RLC Labs Phoeni
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1609-2020·2020-09-23
RLC Labs Recalls WP Thyroid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling WP Thyroid tablets because they were manufactured under conditions found to be subpotent. The recall covers lots expiring between October 2020 and July 2023.
Product
WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoeni
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1605-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets because they were manufactured under conditions associated with subpotent products.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 mcg], 3 Grain (195 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3312-4; b) 60-count bottles, NDC 64727-3312-5; c) 90-count bottles, NDC 64727-3312-6; d) 100-count bottles, NDC 64727-3312-1
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1596-2020·2020-09-23
RLC Labs Recalls Nature-Throid Tablets Due to CGMP Deviations
RLC Labs Inc. is recalling Nature-Throid tablets because they were manufactured under conditions found to be subpotent.
Product
Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mcg], 1 Grain (65 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3300-4; b) 60-count bottles, NDC 64727-3300-5; c) 90-count bottles, NDC 64727-3300-6; d) 100-count bottles, NDC 64727-3300-1; an
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-1585-2020·2020-09-23
Exela Pharma Recalls Potassium Acetate Injection Vials Due to Short Fill
Exela Pharma Sciences LLC is voluntarily recalling 23,775 vials of Potassium Acetate Injection, USP due to short fill issues.
Product
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1563-2020·2020-09-16
Open Book Extracts Recalls Hand Sanitizer Labeled With Methanol
Open Book Extracts is recalling Always Be Clean Hand Sanitizer because it is labeled to contain methanol. The recall covers 340,000 packs distributed nationwide.
Product
Always Be Clean Hand Sanitizer (73% Alcohol) 0.04 FL OZ (1.2 mL) packaged in a) Single snaps (NDC 75091-2020-1 UPC 375091202016); b) 100-count boxes (NDC 75091-2020-2 UPC 375091202023); c) 25-count boxes (NDC 75091-2020-3 UPC 375091202030)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1565-2020·2020-09-16
Shine & Clean Hand Sanitizer Recalled for Methanol and Low Ethanol
Maquiladora Miniara S.A. de C.V. is recalling Shine & Clean Hand Sanitizer gel because FDA testing found undeclared methanol and ethanol levels below the label claim.
Product
Shine & Clean Hand Sanitizer gel, (Ethyl Alcohol 70%), 33.81 fl oz (1L) bottle, Made in Mexico By: Maquiladora Miniara S.A. de C.V. Carrerera Teoloyucan Huehuetoca km: 22 S/N La Planada Mexico C.P.: 54665 NDC 76753-001-01
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1564-2020·2020-09-16
Just Hand Sanitizer Recalled for Methanol Labeling Error
Open Book Extracts is recalling Just Hand Sanitizer because it was labeled to contain methanol.
Product
Just Hand Sanitizer (Ethyl Alcohol 73%) Single Use-Packs 100-count NDC 78065-2020-2 UPC 703123998598 (Single packs NDC 78065-2020-1 UPC 703123998659) Distributed by: Just Hand Sanitizer
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0012-2021·2020-09-16
Teva Recalls Cephalexin Oral Suspension Due to CGMP Deviations
Teva Pharmaceuticals is recalling specific lots of Cephalexin for Oral Suspension because current Good Manufacturing Practice deviations may cause active ingredient levels to fall outside specification limits.
Product
CEPHALEXIN — CEPHALEXIN (CEPHALEXIN)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1566-2020·2020-09-16
Teva Recalls Cephalexin Oral Suspension Due to Low Potency
Teva Pharmaceuticals is recalling Cephalexin for Oral Suspension because test results showed the drug was below the required potency specification.
Product
CEPHALEXIN — CEPHALEXIN (CEPHALEXIN)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1562-2020·2020-09-16
Edge Pharma Recalls Vancomycin IV Bags Due to Labeling Error
Edge Pharma, LLC is recalling Vancomycin HCL 1.5 mg IV bags distributed in Wisconsin due to a label error regarding the declared strength.
Product
Vancomycin HCL 1.5 mg Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 NDC 05446-1458-01
Category
Drug
Distribution
1 state
ModerateFDA (Drugs)·D-0013-2021·2020-09-16
Teva Recalls Cephalexin Oral Suspension Due to CGMP Deviations
Teva Pharmaceuticals is recalling Cephalexin for Oral Suspension because current Good Manufacturing Practice deviations may cause active ingredient levels to fall outside specification limits.
Product
CEPHALEXIN — CEPHALEXIN (CEPHALEXIN)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1576-2020·2020-09-09
Mylan Recalls Tranexamic Acid Injection Due to Labeling Mix-Up
Mylan Institutional LLC is recalling 1,407 cartons of Tranexamic Acid Injection due to a labeling error that may result in the wrong medication being dispensed.
Product
TRANEXAMIC ACID — TRANEXAMIC ACID (TRANEXAMIC ACID)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1570-2020·2020-09-09
Hand Sanitizer Recalled for Methanol Contamination
AAA Cosmetica is recalling bio aaa Advance Hand Sanitizer because it contains methanol. Consumers should stop using the product.
Product
bio aaa Advance Hand Sanitizer Ethyl Alcohol 70%, Unscented, 16.23 Oz (480 mL), Distributed By: Payless Janitorial Corporation 1341 SW 21 Terrance, Fort Lauderdale, Florida Exported By: E. Audicode S.A. de C.V. Manufactured By: AAA Cosmetica S.A. de C.V. UPC 7 502272 12111 5
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

5801–5825 of 17772